(Q43250835)

17 November 2017

Nmn-esterified fatty acids and lipoprotein lipase activity in patients with cirrhosis of the liver (English)

1 reference

17 November 2017

0 references

CHLOUVERAKIS C

1

1 reference

17 November 2017

HARRIS P

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 September 1961

1 reference

17 November 2017

1 reference

17 November 2017

2

1 reference

17 November 2017

233-239

1 reference

In vivo studies of the role of albumin in endogenous and heparin-activated lipemia-clearing in nephrotic rats

17 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413277

The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413277

Unesterified fatty acid in human blood plasma

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413277

Effect of lipemia and heparin on free fatty acid content of rat plasma

25 May 2018

1 reference

12 December 2020

Lipoprotein lipase response in Laennec's cirrhosis

1 reference

12 December 2020

Human endogenous lipemia clearing activity; studies of lipolysis and effects of inhibitors

1 reference

12 December 2020

Comparison of fat emulsion clearing activities of postheparin plasma and pancreatic lipase

1 reference

12 December 2020

Composition of the Free Fatty Acid Fraction in the Plasma of Human Arterial Blood

1 reference

12 December 2020

Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart

1 reference

12 December 2020

Heparinase. II. Distribution of enzyme in various tissues and its action on natural heparins and certain synthetic anticoagulants

1 reference

12 December 2020

Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal individuals and patients with atherosclerosis

1 reference

12 December 2020

ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN

1 reference

12 December 2020

Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia

1 reference

12 December 2020

Effect of liver on lipolysis by normal and post-heparin sera in the rat

1 reference

12 December 2020

The sites at which plasma clearing activity is produced and destroyed in the rat

1 reference

12 December 2020

Studies on blood lipids during exercise. I. Arterial and venous plasma concentrations of unesterified fatty acids

1 reference

12 December 2020

Heparin-activated clearing factor; standardized test, agewise application, and clinical observations

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2.3.233

1 reference

17 November 2017

1 reference

17 November 2017

PubMed publication ID

13879081

1 reference